| Status | Study |
| Recruiting |
Study Name: Registry of the German CLL Study Group Condition: CLL SLL HCL Richter´ Date: 2015-02-26 |
| Recruiting |
Study Name: CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma Condition: Adult Lymphocyte Depletion Hodgkin Lymphoma Adult Lymphocyte Predominant Hodgkin Lymphoma Date: 2014-06-18 Interventions: Drug: 6,8-bis(benzylthio)octanoic acid |
| Recruiting |
Study Name: Prospective, Multicentric, Phase II Randomized Controlled Trial on Two Parallel Groups Comparing the Efficacy of Two Immunosuppressive Drugs (Methotrexate, Cyclophosphamide) in Large Granular Lymphocytes Leukemia Condition: Large Granular Lymphocytes Leukemia Date: 2013-10-22 Interventions: Drug: Methotrexate methotrexat |
| Completed |
Study Name: Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant Condition: Adult Grade III Lymphomatoid Granulomatosis Adult Nasal Type Extranodal NK/T-cell Lymphoma Date: 2013-10-08 Interventions: Drug: busulfan Given IV |
| Recruiting |
Study Name: Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Myeloid Leukemia With 11q23 (MLL) Date: 2013-04-22 Interventions: Biological: therapeutic allogeneic lymphocytes |
| Recruiting |
Study Name: Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas Condition: Adult Grade III Lymphomatoid Granulomatosis Adult Nasal Type Extranodal NK/T-cell Lymphoma Date: 2013-02-27 Interventions: Drug: brentuximab vedotin Give |
| Recruiting |
Study Name: Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas Condition: Adult Grade III Lymphomatoid Granulomatosis Adult Nasal Type Extranodal NK/T-cell Lymphoma Date: 2013-02-13 Interventions: Other: questionnaire administration |
| Withdrawn |
Study Name: Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma Condition: Adult Nasal Type Extranodal NK/T-cell Lymphoma AIDS-related Diffuse Large Cell Lymphoma Date: 2013-01-15 Interventions: Drug: carmustine Given IV |
| Terminated |
Study Name: Ipilimumab and Local Radiation Therapy in Treating Patients With Recurrent Melanoma, Non-Hodgkin Lymphoma, Colon, or Rectal Cancer Condition: Adult Nasal Type Extranodal NK/T-cell Lymphoma Anaplastic Large Cell Lymphoma Date: 2013-01-14 Interventions: Biological: Ipilimumab Given i |
| Recruiting |
Study Name: Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remissi Date: 2013-01-02 Interventions: Drug: Fludarabine phosphate Gi |